NATAP Reports, the newsletter of the National AIDS Treatment Advocacy Project provides the latest HIV and AIDS treatment information and research (including reports on drugs such as protease inhibitors, nucleosides, non-nucleosides, double protease combinations), as well as providing comprehensive reports and developments from the NATAP NYU Forum, the Fourth Retroviruses and Opportunistic Infections conference, as well as from the ICAR, ICAAC, IDSA, European and International HIV and AIDS conferences.
|NATAP Reports #3-4 vol. 1/no. 3-4 (January 1998) A special double issue! - with articles on combination treatments, nevirapine, protease inhibitors, viral load, and drugs in development. Includes reports from the NATAP NYU Forum on Resistance and Cross-resistance, as well as from the IDSA, Hamburg, and ICAAC conferences.|
|To download the entire issue of NATAP Reports #3-4 (January 1998) click here on pdf|
NATAP Reports #2 vol. 1/no. 2 (July 1997) (modified 8/21/97) with articles on combination treatments, nevirapine, protease inhibitors, viral load, and drugs in development.
|NATAP Reports #1 vol. 1/ no. 1 (February 1997) (modified 2/25/97) Special Issue of NATAP's newsletter covering the Fourth Conference on Retroviruses and Opportunistic Infections.|
NATAP is committed to providing the most
comprehensive and real-time up-to-date treatment information available. When there are
advances in AIDS treatment we will publish them either in our newsletter or on our web
|You can download the above files to your computer with Adobe Acrobat Reader (TM) format for easy printing by clicking on pdf . To download Adobe Acrobat Reader software for free, click on the icon below.|